Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Honda Leadership Crisis Deepens as Retired Executives Challenge CEO Toshihiro Mibe’s Strategy
Trump Signals Opposition to USMCA Renewal as U.S. Reviews Trade Relations with Canada and Mexico
Asian Stocks Rebound as AI and Chip Shares Recover; Easing Iran Tensions Boost Sentiment
J.P. Morgan Sees Major Upside for Prysmian as Optical Fiber Prices Surge
MOL Gets More Time to Negotiate Acquisition of Russian-Owned Stake in Serbia’s NIS
Gold Prices Slide Nearly 2% Ahead of Key U.S. Inflation Data and Rising Middle East Tensions
Asian Currencies Gain as U.S. Dollar Softens Ahead of Key Inflation Data in 2026
Changchun Targets EV Growth as China’s Auto Industry Consolidation Accelerates
oOh!media Takeover Battle Intensifies as Bain Capital Joins Competing Bids
US Dollar Dips as Middle East Tensions Ease; Markets Await Key US Inflation Data
Asics Considers Onitsuka Tiger Spinoff as Luxury Sneaker Brand Expands Globally
Sigma Healthcare Shares Slide Amid Preliminary Boots Acquisition Talks
Oil Prices Surge Above $93 as Trump Escalates Iran Pressure and Strait of Hormuz Tensions Deepen
China Trade Surplus Surges in May 2026 as Exports and AI-Driven Imports Accelerate
Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit
Kremlin Says New EU Sanctions Won’t Hurt Russian Banks
Japan Producer Prices Surge in May, Strengthening Expectations of BOJ Rate Hike 



